SCHEMBL4975748

SCHEMBL4975748

NC(=O)NC(=O)CCCC(=O)O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC22A6 Q4U2R8 1/20 0.52
LMNA P02545 4/20 0.46
TSHR P16473 3/20 0.44
THRB P10828 2/20 0.44
BLM P54132 2/20 0.44
KMT2A Q03164 2/20 0.44
NPSR1 Q6W5P4 2/20 0.44
GABRR3 A8MPY1 1/20 0.44
GABRP O00591 1/20 0.44
GABRD O14764 1/20 0.44
HDAC3 O15379 1/20 0.44
GABBR2 O75899 1/20 0.44
CYP1A2 P05177 1/20 0.44
GABRA1 P14867 1/20 0.44
GABRB1 P18505 1/20 0.44
GABRG2 P18507 1/20 0.44
GABRR1 P24046 1/20 0.44
GABRB3 P28472 1/20 0.44
GABRR2 P28476 1/20 0.44
SLC6A1 P30531 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4979808 0.85 PHF8 (0.56) LMNATSHRCYP1A2GABRR1NFKB1
SCHEMBL2510241 0.82 SLC22A6 (0.48) SLC22A6LMNATSHRTHRBBLM
SCHEMBL4979278 0.82 SLC22A6 (0.48) SLC22A6LMNATSHRTHRBBLM
SCHEMBL4975915 0.80 SLC22A6 (0.58) SLC22A6LMNATSHRTHRBBLM
Succinic Acid SCHEMBL28081664 0.76 LMNA (0.56) SLC22A6LMNATSHRTHRBBLM
SCHEMBL4977573 0.76 SLC22A6 (0.52) SLC22A6LMNATSHRKMT2ANPSR1
SCHEMBL4727560 0.76 MAPT (0.52) KMT2ANPSR1ALDH1A1KDM4EMEN1
SCHEMBL28483121 0.76 FAAH (0.38) KMT2ANPSR1HDAC3HDAC1HDAC2
SCHEMBL12967769 0.76 SLC22A6 (0.52) SLC22A6LMNATSHRTHRBBLM
SCHEMBL14895816 0.76 CYP2D6 (0.48) LMNATSHRTHRBBLMKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1685114-B1 ANTIBACTERIAL AND/OR ANTIPROTOZOAL NITROIMIDAZOLE DERIVATIVE COMPOUNDS WITH UREASE INHIBITOR ACTIVITY, PROCESS FOR PREPARING THESE COMPOUNDS AND USE IN PHARMACEUTICAL COMPOSITIONS AND MEDICINES. EMS SA (BR) 2008-10-15 EP claimed
WO-2016094846-A1 INHIBITORS OF CELLULAR NECROSIS AND RELATED METHODS PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2016-06-16 WO disclosed
EP-0458327-B1 Ureidoperoxycarboxylic acids, process for their preparation and their use HOECHST AG (DE) 1995-08-09 EP disclosed
US-5292451-A For bleaching, oxidizing, or disinfecting HOECHST AKTIENGESELLSCHAFT (DE) 1994-03-08 US disclosed
US-5149864-A Oxidation of uridocaroxylic acid derivative with hydrogen peroxide in presence of strong acidic catalyst HOECHST AKTIENGESELLSCHAFT (DE) 1992-09-22 US disclosed
EP-0458327-A1 Ureidoperoxycarboxylic acids, process for their preparation and their use HOECHST AKTIENGESELLSCHAFT (DE) 1991-11-27 EP disclosed